Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Mar 23, 2012

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said this week that it has appointed David Sabatini to its scientific advisory board. Sabatini is a member of the Whitehead Institute for Biomedical Research, where he studies the basic mechanisms of cell growth. He has several affiliations with the Massachusetts Institute of Technology, serving as senior associate member of The Broad Institute, a member of the David H. Koch Institute for Integrative Cancer Research, and associate professor of biology. He also is an investigator at the Howard Hughes Medical Institute.

French biotech company Meiogenix has appointed its scientific advisory board. The company has named Alain Nicolas to chair the SAB. Nicolas is a group leader at the Research Center of the Curie Institute and invented the Meiogenix technology that stimulates homologous recombination of targeted sites in the genome.

The SAB also will include Holger Puchta, chair of plant molecular biology and biochemistry at the Karlsruhe Institute of Technology, and Philip Avner, head of the mouse molecular genetics unit and the developmental biology department at the Pasteur Institute.

The Belgian bioinformatics and PCR company Biogazelle has appointed Kris Vanhercke to be chief operating officer. The company is a spinoff from Ghent University and specializes in qPCR experiment design and data analysis.

The Critical Path Institute has added four new members to its board, and has named current board member Peter Corr to be the new board chairman.

The new members include Craig Brater, dean of the Indiana University School of Medicine; Samuel Broder, executive VP and chief medical officer at Celera Genomics; James Greenwood, president and CEO of the Biotechnology Industry Organization; and Richard Myers, a member of the Arizona Board of Regents.

Cartagenia, which develops software to automate genetic analysis, has hired Drew Arnold as vice president of sales and business development in North America, where he will head the company's new office in Boston, Mass. Arnold was previously at GenomeQuest, where he headed its global sales team. He has also held positions at Silicon Informatics and Lion Bioscience.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.